DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function

PHASE4CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

April 30, 2008

Conditions
Ventricular Ejection Fraction
Interventions
DRUG

Definity® Vial for (Perflutren Lipid Microsphere) Injectable Suspension

The intervention for this study was that all patients received a slow bolus injection of diluted DEFINITY during the contrast-enhanced imaging study.

Trial Locations (10)

15213

University of Pittsburgh Medical Center, Pittsburgh

20010

Washington Hospital Center, Washington DC

27710

Duke University Medical Center, Durham

44195

Cleveland Clinic Foundation, Cleveland

60637

University of Chicago Medical Center, Chicago

64111

Saint Lukes Mid America Heart Institute, Kansas City

68198

University of Nebraska Medical Center, Omaha

77555

University of Texas Medical Branch, Galveston

85727

University of Arizona, Tucson

97239

Oregon Health & Science University, Portland

Sponsors
All Listed Sponsors
lead

Lantheus Medical Imaging

INDUSTRY